Oral Amiodarone Initiation for Rapid Atrial Fibrillation
For oral amiodarone initiation in rapid atrial fibrillation, administer a loading dose of 600 mg daily divided into three doses for one week, followed by 400 mg daily in two divided doses for three weeks, then reduce to a maintenance dose of 100-200 mg daily 1, 2.
Loading Regimen
The standard oral loading protocol consists of:
- Week 1: 600 mg/day in 3 divided doses (200 mg three times daily)
- Weeks 2-4: 400 mg/day in 2 divided doses (200 mg twice daily)
- Maintenance: 100-200 mg daily 1
This loading approach delivers 6-10 grams over 2-4 weeks, which is necessary given amiodarone's extremely long half-life (26-107 days orally) 1. The high loading dose is required to achieve therapeutic tissue concentrations more rapidly, as steady-state would otherwise take months.
Expected Time to Conversion
Expect cardioversion to occur within 36-96 hours in most patients 3, 4, 5. Studies show:
- 80-87% conversion rate with oral amiodarone
- Mean conversion time of 20 hours with oral loading 6
- Most conversions occur after 6-8 hours of therapy initiation 7
- Larger left atrial size and longer AF duration predict slower conversion 4, 5
Critical Monitoring Requirements
Baseline Testing (Before Initiation)
- 12-lead ECG to assess QTc interval and conduction abnormalities
- Liver function tests (AST/ALT) - amiodarone can cause hepatotoxicity
- Thyroid function (TSH, free T4)
- Chest X-ray for baseline pulmonary assessment
- Transthoracic echocardiography to assess left atrial size and ventricular function 8
Follow-Up Monitoring
- Every 3-6 months: Liver enzymes, thyroid function, serum creatinine
- 12-lead ECG at follow-up visits to monitor QTc prolongation
- More frequent monitoring if taking other QT-prolonging drugs 1
Patient Selection Considerations
Amiodarone is specifically recommended for patients with structural heart disease, heart failure with reduced ejection fraction (HFrEF), coronary artery disease, or severe left ventricular hypertrophy 8. This is the key clinical niche where amiodarone excels, as other agents (flecainide, propafenone) are contraindicated in these populations 8, 7.
Contraindications to Consider
- Advanced conduction disturbances without pacing 8
- Baseline QTc >500 ms 8
- Severe sinus node dysfunction 8
Important Caveats
Avoid grapefruit juice during oral amiodarone therapy, as it inhibits CYP3A4-mediated metabolism and increases plasma levels 2.
Amiodarone has significant extracardiac toxicity requiring careful long-term monitoring 8. The most concerning adverse effects include:
- Pulmonary toxicity (potentially fatal)
- Hepatotoxicity (can progress to hepatocellular necrosis) 2
- Thyroid dysfunction (both hypo- and hyperthyroidism)
- Corneal deposits (usually benign)
- Photosensitivity
Alternative: Combined IV-to-Oral Approach
If more rapid control is needed, you can combine IV and oral dosing to complete the loading regimen faster 1. Start with IV amiodarone (150-300 mg over 1 hour, then 10-50 mg/hour) while simultaneously initiating oral therapy at 600 mg/day 4, 5. This hybrid approach achieves therapeutic levels more quickly while transitioning to outpatient oral maintenance.
The oral-only approach is preferred when rapid cardioversion is not urgently needed and allows for outpatient management with close follow-up 4.